Medtronic launches study of surgical technique for treating heart disease

Medtronic has announced the launch of a real-world study assessing the benefits of a new surgical approach for treating aortic disease patients.

The first patient has been enrolled in ENCHANT, a study involving approximately 150 patients across 25 sites in Europe and Russia, which will evaluate the safety and performance of ChEVAR procedures using the Endurant II/IIs stent graft system.

ChEVAR procedures involve a parallel graft chimney technique combining covered renal stents with a standard aortic stent graft. This is the first study to assess this technique among patients with complex aneurysms with short infrarenal neck lengths in a real-world setting.

Researchers will be looking to determine the proportion of enrolled patients who experience technical success at the time of the index procedure and are free from secondary interventions after one year.

Daveen Chopra, vice-president and general manager of Medtronic's aortic business, said: "This is the first industry-sponsored study to evaluate the ChEVAR technique in this patient population, and is another testament of our ongoing commitment to innovation in complex aortic disease and superior clinical outcomes."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.